Action Cancer Genetics - CGIX

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

4,61

Prix Achat

4,56

Prix Vente

4,63

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

4,61

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Cancer Genetics and StemoniX Announce Merger Closing

Cancer Genetics, Inc. Renamed to Vyant Bio, Inc. Vyant Bio, Inc. will begin trading on Nasdaq under the symbol...

Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX

Combined entity creates an innovative platform to de-risk and accelerate the discovery and development of...

Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development

RUTHERFORD, N.J., March 18, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an...

Cancer Genetics to Present at the Annual 33rd ROTH Conference

RUTHERFORD, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an...

Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference

RUTHERFORD, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an...

Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules

RUTHERFORD, N.J., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a...

Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules

RUTHERFORD, N.J., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a...

Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market

RUTHERFORD, N.J., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a...

Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market

RUTHERFORD, N.J., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a...

Cancer Genetics to Present at the 2021 BioConnect Virtual Conference Hosted by H.C. Wainwright

RUTHERFORD, N.J., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

CGIX - Frequently Asked Questions (FAQ)

What is the current Cancer Genetics share price?

The current share price of Cancer Genetics is US$ 4,61

What is the 1 year trading range for Cancer Genetics share price?

Cancer Genetics has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
BTOGBit Origin Ltd	US$ 0,9285 (410,16%)	58,85M
ACONAclarion Inc	US$ 6,50 (94,03%)	11,5M
FTFTFuture FinTech Group Inc	US$ 0,3205 (58,66%)	26,52M
BSCUInvesco BulletShares 2030 Corporate Bond ETF	US$ 24,99 (50,45%)	3
LGHLWLion Group Holding Ltd	US$ 0,0093 (38,81%)	10
LXRXLexicon Pharmaceuticals Inc	US$ 0,32 (-54,25%)	4,66M
BSCSInvesco Bulletshares 2028 Corporate Bond ETF	US$ 10,01 (-50,79%)	1
TOIIWOncology Institute Inc	US$ 0,02 (-45,80%)	1
AGMHAGM Group Holdings Inc	US$ 0,198 (-39,74%)	389,35k
CTKBCytek Biosciences Inc	US$ 2,71 (-39,64%)	3
BTOGBit Origin Ltd	US$ 0,9285 (410,16%)	58,85M
FTFTFuture FinTech Group Inc	US$ 0,3205 (58,66%)	26,52M
ARBKArgo Blockchain PLC	US$ 0,438 (7,51%)	17,11M
ACONAclarion Inc	US$ 6,50 (94,03%)	11,5M
ADTXAditxt Inc	US$ 0,0629 (1,94%)	11,45M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cancer Genetics Inc (CGIX)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

CGIX Dernières nouvelles

Cancer Genetics and StemoniX Announce Merger Closing

Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX

Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development

Cancer Genetics to Present at the Annual 33rd ROTH Conference

Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference

Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules

Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules

Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market

Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market

Cancer Genetics to Present at the 2021 BioConnect Virtual Conference Hosted by H.C. Wainwright

CGIX - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cancer Genetics Inc (CGIX) Cours

Cancer Genetics Inc (CGIX)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

CGIX Dernières nouvelles

Cancer Genetics and StemoniX Announce Merger Closing

Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX

Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development

Cancer Genetics to Present at the Annual 33rd ROTH Conference

Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference

Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules

Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules

Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market

Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market

Cancer Genetics to Present at the 2021 BioConnect Virtual Conference Hosted by H.C. Wainwright

CGIX - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS